AL
Advent Life Sciences
Venture CapitalActiveAdvent Life Sciences is one of Europe√Ґ¬А¬Щs leading venture teams investing in life sciences businesses.
39
Investments
6
Exits
$500M
AUM
15.4%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Advent Life Sciences.
Investment Thesis & Strategy
Advent Life Sciences invests in various stages of life sciences businesses across Europe. They seek to invest in leading venture teams.
Investment Activity
Deals per year over the last 11 years
2
20080
20091
20102
20111
20122
20131
20142
20150
20160
20171
2018Portfolio Companies
Selected investments from their portfolio of 39 companies
R
Respirion
Biotech · Series A, 2018
L
LogicBio Therapeutics
Biotech · Series A, 2015
S
Synthace
Biotech · Series A, 2015
V
Valerion Therapeutics
Biotech · Series A, 2014
O
ObsEva
Biotech · Series A, 2013
Q
Quanta Dialysis Technologies
Healthcare · Series A, 2013
G
GenSight Biologics
Biotech · Series A, 2012
A
Autifony Therapeutics
Biotech · Series A, 2011
A
Atox Bio
Biotech · Series A, 2011
K
Kymab
Biotech · Series A, 2010
A
Adaptimmune
Biotech · Series A, 2008
F
F-star Therapeutics
Biotech · Series A, 2008
Notable Exits
CompanyTypeYearValue / Acquirer
RespirionAcquisition2023—
F-star TherapeuticsAcquisition2022$161M
KymabAcquisition2021$1.4B
Atox BioAcquisition2020—
Adaptimmune TherapeuticsIPO2015$200M
SyntaxinAcquisition2013—
Frequently Asked Questions
Advent Life Sciences focuses on Series A, Series B, Series C+ stage investments.